Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
The AI Platform for Pharma Commercialization
Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
Earendil Labs is a biotechnology company developing technology platforms that transform therapeutic protein discovery.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Waiv is an AI precision medicine company with a vision to find the right drug for every patient.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
Sanofi has invested in 127 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 18 different industry categories.
Among tracked funding rounds, Earendil Labs received $787.0M in a Venture - Series Unknown round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $103.0M across its portfolio of 127 companies.
Recent Sanofi portfolio additions include Epicrispr Biotechnologies, MapLight Therapeutics, Scribe Therapeutics, Q32 Bio, MeiraGTx. These companies were founded in 2020 or later.